Periodontal Disease – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Periodontal Disease – Drugs In Development, 2024 report and make more profitable business decisions.
Periodontal disease is a serious condition that affects the tissues surrounding the teeth, such as the gums, ligaments, and bone. It is caused by bacteria in dental plaque that trigger an inflammatory response in the body. If not treated, periodontal disease can lead to tooth loss, gum abscess, and other complications. Some of the symptoms of periodontal disease are red, swollen, bleeding, or receding gums, bad breath, loose teeth, and painful chewing. To prevent or treat periodontal disease, it is important to maintain good oral hygiene by brushing and flossing daily, and to visit a dentist regularly for professional cleaning and checkup. In some cases, antibiotics or surgery may be needed to control the infection and restore the health of the mouth.
The Periodontal Disease drugs in development market research report provide comprehensive information on the therapeutics under development for Periodontal Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Periodontal Disease and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Periodontal Disease | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 37 molecules, with 30 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Periodontal Disease therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Periodontal Disease pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Periodontal Disease treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Amyndas Pharmaceuticals LLCAvicanna Inc
Beijing SH biotechnology Co Ltd
Bessor Pharma LLC
Cellatoz Therapeutics Inc
Cells for Cells SA
Cytopeutics Pte Ltd
Denteric Pty Ltd
Geistlich Pharma AG
GEXVal Inc
HysensBio Corp
Keystone Bio Inc
KIMS Pharmaceutical Co Ltd
Lighthouse Pharmaceuticals Inc
MetiMedi Pharmaceuticals Co Ltd
Noveome Biotherapeutics Inc
P4 Microbiome Inc
Pacgen Life Science Corp
Periomics Care LLC
PerioTrap Pharmaceuticals GmbH
Petragen Inc
Quince Therapeutics Inc
The Forsyth Institute
Traverse Biosciences Inc
True Node Sciences Inc
University of Florida
University of Louisville
University of Malaya
University of Pennsylvania
US Army Medical Research & Materiel Command
Vaxcyte Inc
Virtici LLC
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Periodontal Disease reports